About 6 in 10 people say they probably won’t get an updated shot this year, despite the CDC’s recommendation that everyone do so, according to results of a new survey from the Pew Research Center.
More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.
The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.
The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.